EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04596-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Shaheen Ali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology, Jamia Hamdard, New Delhi, 110062, India. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 131 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology, Jamia Hamdard, New Delhi, 110062, India.
- Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
- Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. oalam@jamiahamdard.ac.in.
Zitieren
APA
Ali, S., Ilyas, A., Nazar, S., Jha, M., Mathur, V., Tanweer, S., Grover, S., & Alam, O. (2026). EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04596-9
Vancouver
Ali S, Ilyas A, Nazar S, Jha M, Mathur V, Tanweer S, et al. EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04596-9
BibTeX
@article{Ali2026,
author = {Ali, Shaheen and Ilyas, Anam and Nazar, Shagufi and Jha, Mukund and Mathur, Vishal and Tanweer, Sana and Grover, Sonam and Alam, Ozair},
title = {EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04596-9}
}
EUVIMED